Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IMV Inc IMVIF

Healthcare Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.


GREY:IMVIF - Post by User

IMV Inc > RS virus
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(1)
•••
Comment by Jthom376on Aug 15, 2021 7:53pm
312 Views
Post# 33707932

RE:RE:RE:RE:RS virus

RE:RE:RE:RE:RS virus

Come across lots of articles with IMV noted and their Lipid Nano Particle formulated with DPX covid vaccine... published in q2 2021.... but yep... never got an answer either. Still showing in pre clinical don WHO web site. very interesting site looking up reference material. Bit difficult to sort thru the mountain of information  

https://scholar.google.com/scholar?hl=en&as_sdt=0%2C15&as_ylo=2021&as_vis=1&q=imv+inc&btnG=

<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities